Y. Alenezi

From Evidence to Implementation: FIB-4-Based Risk Stratification for Advanced Liver Disease in Saudi Primary Care

Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly common and poses a growing challenge for health systems, because most affected people are managed outside specialist liver services. The clinically important task is not simply to identify hepatic steatosis, but to find the smaller subgrou...